170 related articles for article (PubMed ID: 23470076)
1. Cystatin C: an emerging biomarker in cardiovascular disease.
Angelidis C; Deftereos S; Giannopoulos G; Anatoliotakis N; Bouras G; Hatzis G; Panagopoulou V; Pyrgakis V; Cleman MW
Curr Top Med Chem; 2013; 13(2):164-79. PubMed ID: 23470076
[TBL] [Abstract][Full Text] [Related]
2. Severe obstructive sleep apnea increases cystatin C in clinically latent renal dysfunction.
Kato K; Takata Y; Usui Y; Shiina K; Asano K; Hashimura Y; Saruhara H; Nishihata Y; Tomiyama H; Yamashina A
Respir Med; 2011 Apr; 105(4):643-9. PubMed ID: 21183327
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of kidney function and prediction of death from cardiovascular and other causes in the elderly: A 9-year follow-up study.
Salminen M; Laine K; Korhonen P; Wasen E; Vahlberg T; Isoaho R; Kivelä SL; Löppönen M; Irjala K
Eur J Intern Med; 2016 Sep; 33():98-101. PubMed ID: 27370901
[TBL] [Abstract][Full Text] [Related]
4. [Cystatin C and cardiovascular risk].
Taglieri N; Koenig W; Kaski JC
Ann Biol Clin (Paris); 2010; 68(5):517-29. PubMed ID: 20870574
[TBL] [Abstract][Full Text] [Related]
5. Cystatin C: not just a marker of kidney function.
Fernando S; Polkinghorne KR
J Bras Nefrol; 2020 Mar; 42(1):6-7. PubMed ID: 32255469
[No Abstract] [Full Text] [Related]
6. Prognostic value of chronic kidney disease in patients with coronary heart disease: role of estimating equations.
Zhang QL; Brenner H; Koenig W; Rothenbacher D
Atherosclerosis; 2010 Jul; 211(1):342-7. PubMed ID: 20347445
[TBL] [Abstract][Full Text] [Related]
7. Long-term prognostic value for patients with chronic heart failure of estimated glomerular filtration rate calculated with the new CKD-EPI equations containing cystatin C.
Zamora E; Lupón J; de Antonio M; Vila J; Peñafiel J; Galán A; Urrutia A; Domingo M; Bayes-Genis A
Clin Chem; 2014 Mar; 60(3):481-9. PubMed ID: 24255081
[TBL] [Abstract][Full Text] [Related]
8. [The importance of NGAL and cystatin C biomarkers in cardiovascular diseases].
Helánová K; Pařenica J; Dlouhý V; Pávková Goldbergová M; Cermáková Z; Gottwaldová J; Spinar J
Vnitr Lek; 2012 Apr; 58(4):286-90. PubMed ID: 22559802
[TBL] [Abstract][Full Text] [Related]
9. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation incorporating both cystatin C and creatinine best predicts individual risk: a cohort study in 444 patients with chronic kidney disease.
Rogacev KS; Pickering JW; Seiler S; Zawada AM; Emrich I; Fliser D; Heine GH
Nephrol Dial Transplant; 2014 Feb; 29(2):348-55. PubMed ID: 24166454
[TBL] [Abstract][Full Text] [Related]
10. Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease.
Svensson-Färbom P; Ohlson Andersson M; Almgren P; Hedblad B; Engström G; Persson M; Christensson A; Melander O
J Intern Med; 2014 May; 275(5):506-21. PubMed ID: 24279862
[TBL] [Abstract][Full Text] [Related]
11. How to understand the association between cystatin C levels and cardiovascular disease: Imbalance, counterbalance, or consequence?
Salgado JV; Souza FL; Salgado BJ
J Cardiol; 2013 Dec; 62(6):331-5. PubMed ID: 23849291
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C and cardiovascular risk.
Taglieri N; Koenig W; Kaski JC
Clin Chem; 2009 Nov; 55(11):1932-43. PubMed ID: 19713275
[TBL] [Abstract][Full Text] [Related]
13. Estimated glomerular filtration rate by serum cystatin C correlates with cardiometabolic parameters in patients with primary hyperparathyroidism.
Ermetici F; Filopanti M; Verga U; Passeri E; Dito G; Malavazos AE; Mapelli C; Raggi ME; Spada A; Corbetta S
Eur J Endocrinol; 2015 Oct; 173(4):441-6. PubMed ID: 26194503
[TBL] [Abstract][Full Text] [Related]
14. Cystatin C and Cardiac Measures in Children and Adolescents With CKD.
Brady TM; Townsend K; Schneider MF; Cox C; Kimball T; Madueme P; Warady B; Furth S; Mitsnefes M
Am J Kidney Dis; 2017 Feb; 69(2):247-256. PubMed ID: 27856090
[TBL] [Abstract][Full Text] [Related]
15. The association between creatinine versus cystatin C-based eGFR and cardiovascular risk in children with chronic kidney disease using a modified PDAY risk score.
Sharma S; Denburg MR; Furth SL
Pediatr Nephrol; 2017 Aug; 32(8):1457-1463. PubMed ID: 28484878
[TBL] [Abstract][Full Text] [Related]
16. Cysteinyl cathepsins in cardiovascular diseases.
Zhang X; Luo S; Wang M; Shi GP
Biochim Biophys Acta Proteins Proteom; 2020 Apr; 1868(4):140360. PubMed ID: 31926332
[TBL] [Abstract][Full Text] [Related]
17. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
[TBL] [Abstract][Full Text] [Related]
18. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome.
Kilic T; Oner G; Ural E; Yumuk Z; Sahin T; Bildirici U; Acar E; Celikyurt U; Kozdag G; Ural D
Atherosclerosis; 2009 Dec; 207(2):552-8. PubMed ID: 19523634
[TBL] [Abstract][Full Text] [Related]
20. [Cistatin C as a novel marker of renal function impairement and cardiovascular risk].
Villeval'de SV; Gudgalis NI; Kobalava ZhD
Kardiologiia; 2010; 50(6):78-82. PubMed ID: 20659033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
